Unveiled during the BioWave event at C-CAMP in Bangalore, the report presents a deep dive into India’s biotech funding landscape from 2020 to 2024. The report reveals that India’s biotech ...

A biotech in­cu­bat­ed by RA Cap­i­tal has se­cured a $57.5 mil­lion Se­ries B to be­gin a mid-stage tri­al for its car­dio drug this quar­ter and … ...

"We're constantly amazed by the groundbreaking solutions from the ON Accelerate teams, and this cohort is an inspiring reflection of Australia's burgeoning strength in biotech and healthcare ...

Or, maybe, it's just a grey wolf with a few tweaks. American biotech company Colossal Biosciences made a surprise announcement Monday, claiming it had brought the dire wolf back from the dead ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Biotech companies are already seeing regulatory delays and plenty of uncertainty after around 3,500 FDA employees were cut by the Trump administration. The biotech industry is already feeling the ...

Biotech executives and venture capital investors are banding together to press Congress to act on Food and Drug Administration layoffs they say are already impacting drug development. In a letter to ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t want to lose to China, warns a national security commission made up ...

The U.S.-based biotechnology company is also known for its ambitious goal of bringing back the extinct woolly mammoth by 2028. This dire wolf pup is among the first of its species born in around ...

After a tough period of layoffs and hiring freezes, many were hoping 2025 would bring some relief to the biotech job market. But so far, that rebound hasn’t quite arrived. From cautious employers to ...

The biotech firm, known for its ambitious de-extinction projects, previously gained attention for its woolly mammoth revival efforts. While Colossal attracts significant funding and celebrity ...